Corin is regulated by miR-19b-1-5p to inhibit Ang II-induced atrial fibrillation

Yichang Zhao1, Yue Gong1, Zhenyu Feng2

  • 1Department of Cardiology, The First Affiliated Hospital of Dalian Medical University, Dalian, People's Republic of China.

Heart Rhythm
|November 20, 2025
PubMed
Abstract

Insights

Corin protein deficiency worsens atrial fibrillation (AF) by increasing cardiac remodeling and fibrosis. MicroRNA miR-19b-1-5p regulates Corin, impacting AF development, suggesting therapeutic potential.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Genetics

Background:

  • Atrial fibrillation (AF) is a common heart arrhythmia with significant mortality.
  • The precise molecular mechanisms of AF remain incompletely understood.
  • Corin protein's role in AF has been observed, but its mechanism is unclear.

Purpose of the Study:

  • To elucidate the molecular mechanisms of AF pathogenesis.
  • To investigate the roles of Corin protein and miR-19b-1-5p in AF.
  • To examine their impact on atrial remodeling.

Main Methods:

  • Utilized an angiotensin II (Ang II)-induced AF mouse model.
  • Assessed atrial remodeling through molecular analysis, histology, and gene expression profiling.
  • Investigated the regulatory relationship between Corin and miR-19b-1-5p.

Main Results:

  • Corin knockdown exacerbated Ang II-induced atrial electrical and structural remodeling.
  • Reduced Corin led to increased atrial size, AF incidence, fibrosis, and oxidative stress.
  • miR-19b-1-5p was identified as a negative regulator of Corin mRNA, influencing AF.

Conclusions:

  • Corin and miR-19b-1-5p provide key insights into AF molecular mechanisms.
  • These molecules represent potential therapeutic targets for AF treatment.
  • Further research into targeting Corin and miR-19b-1-5p is warranted.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
895
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
2.4K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K
Regulation of Heart Rates01:31

Regulation of Heart Rates

The regulation of heart rate is a complex process controlled by the autonomic nervous system (ANS), hormonal influences, and intrinsic cardiac mechanisms. The ANS has two main components: the sympathetic nervous system (SNS) and the parasympathetic nervous system (PNS).
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
3.7K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.3K
Regulation of Stroke Volume01:27

Regulation of Stroke Volume

The regulation of stroke volume, which is the amount of blood the heart pumps out during each heartbeat, is critical for maintaining a healthy circulatory system. Stroke volume is influenced by three main factors: preload, contractility, and afterload.
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
4.6K